Technical Analysis for THNR - Amplify Weight Loss Drug & Treatment ETF
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | N/A | N/A | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Gapped Up | Strength | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.46% | |
| Inside Day | Range Contraction | 0.13% | |
| Gapped Up | Strength | 0.13% | |
| Volume Surge | Other | 0.65% | |
| Gapped Down | Weakness | 0.65% | |
| New 52 Week Closing High | Bullish | -0.44% | |
| New 52 Week High | Strength | -0.44% | |
| Stochastic Reached Overbought | Strength | -0.44% | |
| Upper Bollinger Band Walk | Strength | -0.44% |
| Alert | Time |
|---|---|
| Rose Above Previous Day's High | about 8 hours ago |
| Rose Above Upper Bollinger Band | about 8 hours ago |
| Up 1 ATR | about 8 hours ago |
| Possible Inside Day | 4 days ago |
| 1.5x Volume Pace | 4 days ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
The fund's manager invests at least 80% of its net assets (plus borrowings for investment purposes) in securities that comprise the index. The index is comprised of global companies who are manufacturers in the GLP-1 agonist pharmaceutical business or who enable such business. GLP-1 agonists (glucagon-like peptide) seek to lower blood sugar levels and reduce appetite and promote fullness, with the ultimate potential for weight loss. The fund is non-diversified.
Keywords: Glucagon Glucagon Like Peptide 1 Peptide Therapeutics
Classification
Keywords: Glucagon Glucagon Like Peptide 1 Peptide Therapeutics
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 26.43 |
| 52 Week Low | 24.92 |
| Average Volume | 11,008 |
| 200-Day Moving Average | 0.00 |
| 50-Day Moving Average | 0.00 |
| 20-Day Moving Average | 25.89 |
| 10-Day Moving Average | 26.01 |
| Average True Range | 0.21 |
| RSI (14) | 61.83 |
| ADX | 23.63 |
| +DI | 38.05 |
| -DI | 20.50 |
| Chandelier Exit (Long, 3 ATRs) | 25.80 |
| Chandelier Exit (Short, 3 ATRs) | 25.55 |
| Upper Bollinger Bands | 26.31 |
| Lower Bollinger Band | 25.46 |
| Percent B (%b) | 0.86 |
| BandWidth | 3.29 |
| MACD Line | 0.25 |
| MACD Signal Line | 0.22 |
| MACD Histogram | 0.0312 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 26.43 | ||||
| Resistance 3 (R3) | 26.44 | 26.37 | 26.39 | ||
| Resistance 2 (R2) | 26.37 | 26.31 | 26.36 | 26.38 | |
| Resistance 1 (R1) | 26.28 | 26.27 | 26.24 | 26.27 | 26.37 |
| Pivot Point | 26.21 | 26.21 | 26.19 | 26.20 | 26.21 |
| Support 1 (S1) | 26.12 | 26.14 | 26.08 | 26.11 | 26.01 |
| Support 2 (S2) | 26.04 | 26.10 | 26.04 | 26.00 | |
| Support 3 (S3) | 25.95 | 26.04 | 25.98 | ||
| Support 4 (S4) | 25.94 |
